Jarow named acting director of CDER's OMP

Janet Woodcock, director of FDA's Center for Drug Evaluation and Research, announced in an internal memo that Jonathan Jarow will serve a 120-day detail as acting director of the Office of Medical Policy. Jarow is associate director of CDER's Office of Hematology and Oncology Products (OHOP).

CDER spokesperson Kristofer Baumgartner said the detail is part of Woodcock's selection process for a permanent director. He said it allows Jarow to "try out" the position before the agency makes a final decision. ...